Effect of oral syrup and intranasal spray of Falcaria Vulgaris plant in patients with Covid-19

Phase 3

• Conditions: COVID-19.; Covid-19; U07.1

• Registration Number: IRCT20130722014106N9
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Confirmation of coronavirus infection by CT scan of the chest and PCR test
Age 20 to 70 years
Willingness to cooperate in the study and completion of informed written consent

Exclusion Criteria

pregnant women
children
Elderly (people over 70)
People who use mechanical ventilation
People undergoing chemotherapy
People who receive corticosteroids are excluded from the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood oxygen saturation. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: Pulse oximeter.;Rate of lung involvement. Timepoint: beginning and end of the study. Method of measurement: computed tomography scan.

Secondary Outcome Measures

Name	Time	Method
umber of breaths. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: Counting breaths per minute.;Body temperature. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: thermometer and clinical examination.;Dyspnea. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: clinical examination.;Cough. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: clinical examination.